{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:23:47Z","timestamp":1767626627904},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.expneurol.2006.03.002","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T15:37:09Z","timestamp":1146152229000},"page":"28-36","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacologic management of ischemic stroke: Relevance to stem cell therapy"],"prefix":"10.1016","volume":"199","author":[{"given":"Sid","family":"Gilman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2006.03.002_bib1","first-page":"1711","article-title":"Guidelines for thrombolytic therapy of acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association","volume":"27","author":"Adams","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib2","series-title":"Ischemic Cerebrovascular Disease","author":"Adams","year":"2001"},{"key":"10.1016\/j.expneurol.2006.03.002_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.STR.0000064841.47697.22","article-title":"Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association","volume":"34","author":"Adams","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.STR.0000163257.66207.2d","article-title":"Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association\/American Stroke Association","volume":"36","author":"Adams","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib5","doi-asserted-by":"crossref","first-page":"483S","DOI":"10.1378\/chest.126.3_suppl.483S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Albers","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.expneurol.2006.03.002_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","author":"Anonymous","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib7","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","volume":"333","author":"Anonymous","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1212\/WNL.47.3.835","article-title":"Practice advisory: thrombolytic therapy for acute ischemic stroke\u2014Summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"47","author":"Anonymous","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"Anonymous","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2006.03.002_bib10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.expneurol.2006.03.002_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jnnp.2003.020479","article-title":"Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis","volume":"75","author":"Arnold","year":"2004","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2006.03.002_bib12","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/01.hjh.0000170374.33763.77","article-title":"How to manage blood pressure in acute stroke","volume":"23","author":"Bath","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.expneurol.2006.03.002_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/01.STR.0000153056.25397.ff","article-title":"Approval of the MERCI clot retriever: a critical view","volume":"36","author":"Becker","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.STR.25.3.552","article-title":"Stroke incidence and case fatality in Australasia. A comparison of the Auckland and Perth population-based stroke registers","volume":"25","author":"Bonita","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/exnr.1997.6730","article-title":"Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats","volume":"149","author":"Borlongan","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.STR.27.5.875","article-title":"Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome","volume":"27","author":"Brandt","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.STR.29.2.415","article-title":"The Greater Cincinnati\/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks","volume":"29","author":"Broderick","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1212\/WNL.52.2.280","article-title":"Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators","volume":"52","author":"Bruno","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.59.5.669","article-title":"Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial","volume":"59","author":"Bruno","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.1985.04060070051014","article-title":"Prognostic significance of hyperglycemia in acute stroke","volume":"42","author":"Candelise","year":"1985","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib21","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib22","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/hs1001.096194","article-title":"Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview","volume":"32","author":"Capes","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib23","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.STR.29.12.2455","article-title":"Timing for fever-related brain damage in acute ischemic stroke","volume":"29","author":"Castillo","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.STR.0000109769.22917.B0","article-title":"Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome","volume":"35","author":"Castillo","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib25","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1161\/01.STR.26.11.1990","article-title":"Stroke in China, 1986 through 1990","volume":"26","author":"Cheng","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib26","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2006.03.002_bib27","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5\u00a0hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2006.03.002_bib28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.STR.31.4.811","article-title":"The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators","volume":"31","author":"Clark","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ana.410230117","article-title":"Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients","volume":"23","author":"Crisostomo","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.290.1.86","article-title":"Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review","volume":"290","author":"Critchley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2006.03.002_bib31","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.STR.27.7.1211","article-title":"Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy","volume":"27","author":"Dam","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in acute cerebral thromboembolism","volume":"29","author":"del Zoppo","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib33","series-title":"The Clinical Science of Neurologic Rehabilitation","author":"Dobkin","year":"2003"},{"key":"10.1016\/j.expneurol.2006.03.002_bib34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1474-4422(04)00851-8","article-title":"Strategies for stroke rehabilitation","volume":"3","author":"Dobkin","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/01.STR.18.5.830","article-title":"Disability and use of rehabilitation services following stroke in Rochester, Minnesota, 1975\u20131979","volume":"18","author":"Dombovy","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib36","first-page":"135","article-title":"Pharmacotherapy for recovery of function after brain injury","volume":"3","author":"Feeney","year":"1987","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib37","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/01.STR.0000072983.64326.53","article-title":"Stroke Therapy Academic Industry Roundtable, 2003. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3","volume":"34","author":"Fisher","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.10407","article-title":"New perspectives on developing acute stroke therapy","volume":"53","author":"Fisher","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib39","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1212\/WNL.45.7.1286","article-title":"Large hemispheric infarction, deterioration, and intracranial pressure","volume":"45","author":"Frank","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib40","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2006.03.002_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.STR.29.2.529","article-title":"Combating hyperthermia in acute stroke: a significant clinical concern","volume":"29","author":"Ginsberg","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0317167100052173","article-title":"Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier?","volume":"27","author":"Gladstone","year":"2000","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2006.03.002_bib43","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1161\/01.STR.0000025518.34157.51","article-title":"Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions","volume":"33","author":"Gladstone","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib44","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/01.STR.29.9.1894","article-title":"Local intra-arterial thrombolysis in acute ischemic stroke","volume":"29","author":"Gonner","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0003-9993(98)90169-1","article-title":"Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study","volume":"79","author":"Grade","year":"1998","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.expneurol.2006.03.002_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archneur.1996.00550040037012","article-title":"\u2018Malignant\u2019 middle cerebral artery territory infarction: clinical course and prognostic signs","volume":"53","author":"Hacke","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000072554","article-title":"European Stroke Initiative Recommendations for Stroke Management\u2014Update 2003","volume":"16","author":"Hacke","year":"2003","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.expneurol.2006.03.002_bib48","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","article-title":"The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase","volume":"36","author":"Hacke","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.STR.31.2.410","article-title":"Effects of poststroke pyrexia on stroke outcome. A meta-analysis of studies in patients","volume":"31","author":"Hajat","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib50","doi-asserted-by":"crossref","first-page":"513S","DOI":"10.1378\/chest.126.3_suppl.513S","article-title":"Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Harrington","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.expneurol.2006.03.002_bib51","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/CIRCULATIONAHA.104.503995","article-title":"Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review","volume":"112","author":"Iestra","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.expneurol.2006.03.002_bib116","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0408258102","article-title":"Directed migration of human and mouse neural stem cells to site of CNS injury by the SDF1\u03b1\/CXCR4-dependent pathway","volume":"101","author":"Imitola","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2006.03.002_bib52","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1212\/WNL.61.8.1030","article-title":"Blood pressure reduction in ischemic stroke: a two-edged sword?","volume":"61","author":"Johnston","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib53","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0003-9993(95)80567-2","article-title":"Outcome and time course of recovery in stroke: Part I. Outcome. The Copenhagen Stroke Study","volume":"76","author":"Jorgensen","year":"1995","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.expneurol.2006.03.002_bib54","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0003-9993(95)80568-0","article-title":"Outcome and time course of recovery in stroke: Part II. Time course of recovery. The Copenhagen Stroke Study","volume":"76","author":"Jorgensen","year":"1995","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.expneurol.2006.03.002_bib55","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.STR.31.2.434","article-title":"Who benefits from treatment and rehabilitation in a stroke unit? A community-based study","volume":"31","author":"Jorgensen","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib56","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.STR.0000019910.90280.F1","article-title":"Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study","volume":"33","author":"Kammersgaard","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib57","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/WNL.57.9.1603","article-title":"Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial","volume":"57","author":"Kase","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.STR.0000051506.43212.8B","article-title":"Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3\u00a0hours from symptom onset?","volume":"34","author":"Kent","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib59","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1212\/WNL.57.12.2301","article-title":"Prophylactic antipyretic treatment with acetaminophen in acute ischemic stroke: a pilot study","volume":"57","author":"Koennecke","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.55.4.565","article-title":"Transplantation of cultured human neuronal cells for patients with stroke","volume":"55","author":"Kondziolka","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib61","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1046\/j.1471-4159.1994.62062233.x","article-title":"Spontaneous and amphetamine-evoked release of cerebellar noradrenaline after sensorimotor cortex contusion: an in vivo microdialysis study in the awake rat","volume":"62","author":"Krobert","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.03.002_bib62","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199906103402302","article-title":"Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group","volume":"340","author":"Kwiatkowski","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1527-3458.2003.tb00252.x","article-title":"Development of the nitrone-based spin trap agent NXY-059 to treat acute ischemic stroke","volume":"9","author":"Lapchak","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.expneurol.2006.03.002_bib64","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib65","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archinte.146.1.66","article-title":"Management of hypertension in patients with acute stroke","volume":"146","author":"Lavin","year":"1986","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib66","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1067\/mem.2003.194","article-title":"Beyond tissue plasminogen activator: mechanical intervention in acute stroke","volume":"41","author":"Leary","year":"2003","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib67","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.STR.32.3.675","article-title":"Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke","volume":"32","author":"Lees","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib68","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/01.STR.0000053032.14223.81","article-title":"Tolerability of NXY-059 at higher target concentrations in patients with acute stroke","volume":"34","author":"Lees","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib69","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa052980","article-title":"NXY-059 for acute ischemic stroke","volume":"354","author":"Lees","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib70","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/01.STR.0000132571.77987.4c","article-title":"Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy","volume":"35","author":"Leigh","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib71","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/01.STR.0000014509.11540.66","article-title":"Blood pressure and clinical outcomes in the International Stroke Trial","volume":"33","author":"Leonardi-Bee","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib72","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2006.03.002_bib73","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/01.STR.0000049764.49162.76","article-title":"Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration","volume":"34","author":"Liberatore","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.STR.0000115297.92132.84","article-title":"Hyperglycemia in acute stroke","volume":"35","author":"Lindsberg","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib75","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1212\/WNL.55.11.1649","article-title":"Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study","volume":"55","author":"Marler","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib76","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/01.STR.0000024524.71680.C6","article-title":"Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal","volume":"33","author":"Mayer","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib77","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/S0140-6736(98)06351-X","article-title":"Mortality and light to moderate alcohol consumption after myocardial infarction","volume":"352","author":"Muntwyler","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2006.03.002_bib78","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.STR.0000152331.93770.18","article-title":"Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?","volume":"36","author":"Noser","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib79","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/01.hjh.0000170385.76826.4a","article-title":"Effects of blood pressure levels on case fatality after acute stroke","volume":"23","author":"Okumura","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.expneurol.2006.03.002_bib80","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1212\/01.WNL.0000092498.75010.57","article-title":"Detrimental effect of blood pressure reduction in the first 24\u00a0hours of acute stroke onset","volume":"61","author":"Oliveira-Filho","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.002_bib81","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11940-003-0027-7","article-title":"Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke","volume":"5","author":"Ovbiagele","year":"2003","journal-title":"Curr. Treat. Opt. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib82","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ana.1257","article-title":"Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke","volume":"50","author":"Pariente","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2006.03.002_bib117","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.expneurol.2006.04.002","article-title":"Acute injury directs the migration, proliferation, and the differentiation of solid organ stem cells: evidence from the effect of hypoxia\u2013ischemia in the CNS on clonal \u201creporter\u201d neural stem cells","volume":"199","author":"Park","year":"2006","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2006.03.002_bib118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2006.03.016","article-title":"Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of NT-3-expressing cells in asphyxial brain injury","volume":"199","author":"Park","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib119","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nbt751","article-title":"The injured brain interacts reciprocally with neural stem cells supported on scaffolds to reconstitute lost tissue","volume":"20","author":"Park","year":"2002","journal-title":"Nature Biotech."},{"key":"10.1016\/j.expneurol.2006.03.002_bib83","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ana.10241","article-title":"Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study","volume":"52","author":"Parsons","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib84","doi-asserted-by":"crossref","first-page":"731","DOI":"10.7326\/0003-4819-139-9-200311040-00007","article-title":"Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality","volume":"139","author":"Pastor-Barriuso","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib85","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archinte.152.5.938","article-title":"Hypertension and the brain. The National High Blood Pressure Education Program","volume":"152","author":"Phillips","year":"1992","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib86","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1523\/JNEUROSCI.12-05-01802.1992","article-title":"Pure, postmitotic, polarized human neurons derived from Ntera 2 cells provide a system for expressing exogenous portioned in terminally differentiated neurons","volume":"12","author":"Pleasure","year":"1992","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2006.03.002_bib87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.expneurol.2005.12.011","article-title":"A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke","volume":"199","author":"Pollock","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib88","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00006123-200211000-00040","article-title":"Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study","volume":"51","author":"Qureshi","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.expneurol.2006.03.002_bib89","doi-asserted-by":"crossref","first-page":"494","DOI":"10.7326\/0003-4819-137-6-200209170-00009","article-title":"Smoking status and risk for recurrent coronary events after myocardial infarction","volume":"137","author":"Rea","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib90","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(96)90008-2","article-title":"Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome","volume":"347","author":"Reith","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2006.03.002_bib91","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/ndt\/13.9.2179","article-title":"Hypertension in patients with cerebrovascular accident. To treat or not to treat?","volume":"13","author":"Ringleb","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.expneurol.2006.03.002_bib92","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.STR.30.10.2033","article-title":"Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial","volume":"30","author":"Ronning","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib93","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(01)05966-9","article-title":"Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study","volume":"358","author":"Scheidtmann","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2006.03.002_bib94","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1161\/01.STR.31.7.1552","article-title":"One-year follow-up in acute stroke patients treated with rtPA in clinical routine","volume":"31","author":"Schm\u00fclling","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib95","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/hs0202.102376","article-title":"Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke","volume":"33","author":"Schwarz","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib96","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(05)74948-5","article-title":"Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke","volume":"353","author":"Scott","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2006.03.002_bib97","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.283.18.2395","article-title":"Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial","volume":"283","author":"Sherman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.expneurol.2006.03.002_bib98","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/01.STR.15.3.492","article-title":"Early mortality following stroke: a prospective review","volume":"15","author":"Silver","year":"1984","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib99","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/hc3801.097475","article-title":"AHA\/ACC Scientific Statement: AHA\/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology","volume":"104","author":"Smith","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.expneurol.2006.03.002_bib100","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.STR.0000171066.25248.1d","article-title":"Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial","volume":"36","author":"Smith","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib101","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/01.STR.28.7.1367","article-title":"Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations","volume":"28","author":"Stegmayr","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib102","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/01.STR.29.11.2381","article-title":"Enhanced neocortical neural sprouting, synaptogenesis, and behavioural recovery with d-amphetamine therapy after neocortical infarction in rats","volume":"29","author":"Stroemer","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib103","first-page":"1023","article-title":"Statins after ischemic stroke and transient ischemic attack: an advisory statement from the Stroke Council, American Heart Association and American Stroke Association","volume":"35","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib104","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/01.STR.27.3.550","article-title":"Comparing stroke incidence worldwide: what makes studies comparable?","volume":"27","author":"Sudlow","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1037\/0735-7044.103.4.837","article-title":"Amphetamine accelerates recovery of locomotor function following bilateral frontal cortex ablation in cats","volume":"103","author":"Sutton","year":"1989","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.expneurol.2006.03.002_bib106","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0404.1998.tb05971.x","article-title":"Effect of nimodipine on memory after cerebral infarction","volume":"97","author":"Sze","year":"1998","journal-title":"Acta. Neurol. Scand."},{"key":"10.1016\/j.expneurol.2006.03.002_bib107","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/str.36.7.1439","article-title":"Mechanical embolus removal: a new day dawning","volume":"36","author":"Tomsick","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib108","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1191\/026921599674794965","article-title":"The process of stroke rehabilitation: what happens and why","volume":"13","author":"Tyson","year":"1999","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.expneurol.2006.03.002_bib109","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa003417","article-title":"Impact of high-normal blood pressure on the risk of cardiovascular disease","volume":"345","author":"Vasan","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0196-0644(03)00609-7","article-title":"Association between course of blood pressure within the first 24\u00a0hours and functional recovery after acute ischemic stroke","volume":"42","author":"Vlcek","year":"2003","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.expneurol.2006.03.002_bib111","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.STR.26.12.2254","article-title":"Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence","volume":"26","author":"Walker-Batson","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2006.03.002_bib112","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1368-5031.2004.00245.x","article-title":"NXY-059: a neuroprotective agent in acute stroke","volume":"58","author":"Wang","year":"2004","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.expneurol.2006.03.002_bib113","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.314.7090.1303","article-title":"Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study","volume":"314","author":"Weir","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.expneurol.2006.03.002_bib114","first-page":"892","article-title":"Transarterial embolectomy in acute stroke","volume":"24","author":"Wikholm","year":"2003","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.expneurol.2006.03.002_bib115","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1212\/01.WNL.0000158284.41705.A5","article-title":"Heads down: flat positioning improves blood flow velocity in acute ischemic stroke","volume":"64","author":"Wojner-Alexander","year":"2005","journal-title":"Neurology"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606001907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606001907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T06:18:34Z","timestamp":1586845114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488606001907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0014488606001907"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2006.03.002","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}